Search research articles
Contact Us
Filters
Showing results (191-200 of 279) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study
Roger J Packer, James G Gurney, Judy A Punyko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2010
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
J Russell Geyer, Clinton F Stewart, Mehmet Kocak, et al.
Cancer
|
January 28, 2003
Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study
James G Gurney, Nina S Kadan-Lottick, Roger J Packer, et al.
Acta Neuropathologica
|
December 4, 2013
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M Saratsis, Madhuri Kambhampati, Kendall Snyder, et al.
Neuro-Oncology
|
March 30, 2016
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study
Rishi R Lulla, Stewart Goldman, Tohru Yamada, et al.
Acta Neuropathologica
|
June 21, 2020
Correction to: Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M Saratsis, Madhuri Kambhampati, Kendall Snyder, et al.
Pediatric Blood & Cancer
|
September 6, 2012
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group
James H Garvin, Michael T Selch, Emi Holmes, et al.
Neuro-Oncology
|
May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma
Ute Bartels, Johannes Wolff, Lia Gore, et al.
Journal of Neuro-Oncology
|
October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
Katherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Journal of Neuro-Oncology
|
November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study
Roger J Packer, Brian R Rood, David C Turner, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 279) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study
Roger J Packer, James G Gurney, Judy A Punyko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 2010
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
J Russell Geyer, Clinton F Stewart, Mehmet Kocak, et al.
Cancer
|
January 28, 2003
Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study
James G Gurney, Nina S Kadan-Lottick, Roger J Packer, et al.
Acta Neuropathologica
|
December 4, 2013
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M Saratsis, Madhuri Kambhampati, Kendall Snyder, et al.
Neuro-Oncology
|
March 30, 2016
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study
Rishi R Lulla, Stewart Goldman, Tohru Yamada, et al.
Acta Neuropathologica
|
June 21, 2020
Correction to: Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M Saratsis, Madhuri Kambhampati, Kendall Snyder, et al.
Pediatric Blood & Cancer
|
September 6, 2012
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group
James H Garvin, Michael T Selch, Emi Holmes, et al.
Neuro-Oncology
|
May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma
Ute Bartels, Johannes Wolff, Lia Gore, et al.
Journal of Neuro-Oncology
|
October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
Katherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Journal of Neuro-Oncology
|
November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study
Roger J Packer, Brian R Rood, David C Turner, et al.
Page
of 28